Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Decision Making | 23 | 2023 | 203 | 5.940 |
Why?
|
| Cannabis | 15 | 2023 | 79 | 5.420 |
Why?
|
| Marijuana Abuse | 15 | 2021 | 91 | 4.920 |
Why?
|
| Neuropsychological Tests | 38 | 2022 | 259 | 4.180 |
Why?
|
| Conduct Disorder | 6 | 2021 | 49 | 3.980 |
Why?
|
| Marijuana Smoking | 9 | 2018 | 85 | 3.200 |
Why?
|
| Substance-Related Disorders | 27 | 2021 | 730 | 2.870 |
Why?
|
| Adolescent Behavior | 6 | 2021 | 253 | 2.870 |
Why?
|
| Risk-Taking | 10 | 2019 | 451 | 2.570 |
Why?
|
| Brain | 21 | 2022 | 1346 | 2.540 |
Why?
|
| Gambling | 8 | 2023 | 15 | 2.160 |
Why?
|
| Adolescent | 36 | 2023 | 5363 | 2.030 |
Why?
|
| Cognition | 16 | 2022 | 398 | 2.000 |
Why?
|
| Sex Characteristics | 8 | 2021 | 230 | 1.720 |
Why?
|
| Cognition Disorders | 13 | 2013 | 233 | 1.670 |
Why?
|
| Sexual Behavior | 5 | 2018 | 609 | 1.620 |
Why?
|
| Longitudinal Studies | 13 | 2023 | 885 | 1.580 |
Why?
|
| Humans | 93 | 2023 | 37093 | 1.460 |
Why?
|
| Reward | 4 | 2020 | 79 | 1.380 |
Why?
|
| Psychomotor Performance | 8 | 2015 | 136 | 1.360 |
Why?
|
| Male | 65 | 2021 | 20025 | 1.330 |
Why?
|
| Female | 60 | 2021 | 20969 | 1.250 |
Why?
|
| HIV Infections | 19 | 2021 | 2303 | 1.230 |
Why?
|
| Motivation | 4 | 2021 | 436 | 1.220 |
Why?
|
| Executive Function | 3 | 2019 | 49 | 1.210 |
Why?
|
| Learning | 7 | 2018 | 117 | 1.020 |
Why?
|
| Anxiety Disorders | 2 | 2018 | 309 | 1.000 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2021 | 53 | 0.920 |
Why?
|
| Impulsive Behavior | 6 | 2015 | 46 | 0.920 |
Why?
|
| Attention | 6 | 2019 | 156 | 0.910 |
Why?
|
| Emotions | 3 | 2021 | 220 | 0.890 |
Why?
|
| Memory Disorders | 6 | 2023 | 73 | 0.850 |
Why?
|
| HIV Seropositivity | 11 | 2016 | 190 | 0.840 |
Why?
|
| Child | 14 | 2023 | 3131 | 0.820 |
Why?
|
| Mental Recall | 5 | 2016 | 78 | 0.790 |
Why?
|
| Adult | 45 | 2023 | 11712 | 0.760 |
Why?
|
| Psychometrics | 7 | 2021 | 318 | 0.750 |
Why?
|
| Social Environment | 2 | 2021 | 207 | 0.740 |
Why?
|
| Depressive Disorder | 2 | 2018 | 174 | 0.720 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 2721 | 0.700 |
Why?
|
| Schools | 1 | 2021 | 260 | 0.690 |
Why?
|
| Cannabinoids | 3 | 2019 | 56 | 0.690 |
Why?
|
| Amphetamine-Related Disorders | 4 | 2013 | 65 | 0.680 |
Why?
|
| Medication Adherence | 2 | 2021 | 179 | 0.680 |
Why?
|
| Personality Assessment | 1 | 2019 | 42 | 0.670 |
Why?
|
| Adolescent Development | 4 | 2019 | 31 | 0.650 |
Why?
|
| Multilingualism | 1 | 2019 | 46 | 0.640 |
Why?
|
| Young Adult | 15 | 2019 | 4268 | 0.640 |
Why?
|
| Mood Disorders | 1 | 2018 | 48 | 0.620 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2018 | 282 | 0.610 |
Why?
|
| Methamphetamine | 4 | 2007 | 159 | 0.570 |
Why?
|
| Auditory Perception | 2 | 2006 | 48 | 0.540 |
Why?
|
| Anti-HIV Agents | 3 | 2017 | 420 | 0.540 |
Why?
|
| Prospective Studies | 7 | 2021 | 1378 | 0.530 |
Why?
|
| Mental Processes | 2 | 2012 | 15 | 0.510 |
Why?
|
| Anxiety | 3 | 2017 | 754 | 0.470 |
Why?
|
| Body Mass Index | 2 | 2019 | 854 | 0.440 |
Why?
|
| Choice Behavior | 2 | 2013 | 79 | 0.430 |
Why?
|
| Mental Disorders | 3 | 2021 | 309 | 0.430 |
Why?
|
| Heroin Dependence | 4 | 2015 | 23 | 0.420 |
Why?
|
| Middle Aged | 28 | 2019 | 10129 | 0.410 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2021 | 481 | 0.410 |
Why?
|
| Amygdala | 3 | 2021 | 114 | 0.410 |
Why?
|
| Serial Learning | 1 | 2011 | 2 | 0.400 |
Why?
|
| Memory | 3 | 2013 | 170 | 0.380 |
Why?
|
| Individuality | 2 | 2022 | 46 | 0.370 |
Why?
|
| Analysis of Variance | 7 | 2017 | 550 | 0.360 |
Why?
|
| Cyclonic Storms | 2 | 2021 | 64 | 0.360 |
Why?
|
| Reproducibility of Results | 6 | 2019 | 935 | 0.320 |
Why?
|
| Demography | 3 | 2006 | 175 | 0.300 |
Why?
|
| Alcoholism | 3 | 2007 | 240 | 0.290 |
Why?
|
| Gyrus Cinguli | 3 | 2021 | 25 | 0.290 |
Why?
|
| Case-Control Studies | 4 | 2017 | 1130 | 0.280 |
Why?
|
| Sex Factors | 3 | 2019 | 898 | 0.270 |
Why?
|
| AIDS Dementia Complex | 2 | 2004 | 102 | 0.260 |
Why?
|
| Risk Factors | 5 | 2021 | 3562 | 0.250 |
Why?
|
| Follow-Up Studies | 3 | 2023 | 974 | 0.250 |
Why?
|
| Exploratory Behavior | 1 | 2005 | 75 | 0.250 |
Why?
|
| Depression | 3 | 2023 | 712 | 0.250 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2004 | 35 | 0.240 |
Why?
|
| Drug Users | 3 | 2015 | 46 | 0.240 |
Why?
|
| Comorbidity | 4 | 2018 | 623 | 0.240 |
Why?
|
| Mental Health | 2 | 2018 | 303 | 0.230 |
Why?
|
| Hepatitis C | 3 | 2015 | 125 | 0.230 |
Why?
|
| Cubozoa | 1 | 2023 | 16 | 0.220 |
Why?
|
| Computers | 1 | 2003 | 35 | 0.220 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2021 | 389 | 0.220 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 137 | 0.210 |
Why?
|
| Mass Media | 1 | 2021 | 35 | 0.200 |
Why?
|
| Empathy | 1 | 2021 | 28 | 0.200 |
Why?
|
| Disease Management | 1 | 2021 | 61 | 0.190 |
Why?
|
| Intelligence | 2 | 2019 | 12 | 0.190 |
Why?
|
| Personality | 3 | 2021 | 42 | 0.190 |
Why?
|
| Drug Interactions | 2 | 2015 | 141 | 0.180 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 82 | 0.180 |
Why?
|
| Disasters | 1 | 2020 | 65 | 0.170 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2019 | 47 | 0.170 |
Why?
|
| Vocabulary | 1 | 2019 | 20 | 0.170 |
Why?
|
| Antisocial Personality Disorder | 2 | 2010 | 17 | 0.170 |
Why?
|
| Cohort Studies | 3 | 2021 | 1492 | 0.170 |
Why?
|
| Reaction Time | 4 | 2010 | 143 | 0.170 |
Why?
|
| Brain Mapping | 1 | 2019 | 112 | 0.160 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 146 | 0.160 |
Why?
|
| Behavior, Addictive | 1 | 2018 | 32 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 173 | 0.160 |
Why?
|
| Aggression | 1 | 2019 | 89 | 0.160 |
Why?
|
| Models, Statistical | 1 | 2019 | 180 | 0.160 |
Why?
|
| Verbal Learning | 3 | 2013 | 15 | 0.150 |
Why?
|
| Self Administration | 1 | 2017 | 42 | 0.150 |
Why?
|
| Social Class | 1 | 2019 | 247 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 519 | 0.140 |
Why?
|
| Regression Analysis | 3 | 2013 | 455 | 0.140 |
Why?
|
| United States | 4 | 2019 | 4223 | 0.140 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2016 | 2 | 0.140 |
Why?
|
| Behavior | 1 | 2016 | 32 | 0.140 |
Why?
|
| Parents | 1 | 2019 | 329 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2019 | 646 | 0.130 |
Why?
|
| Cocaine-Related Disorders | 3 | 2016 | 85 | 0.130 |
Why?
|
| Age of Onset | 1 | 2015 | 100 | 0.130 |
Why?
|
| Intelligence Tests | 2 | 2011 | 7 | 0.120 |
Why?
|
| Reference Values | 2 | 2012 | 212 | 0.120 |
Why?
|
| Visual Perception | 2 | 2016 | 67 | 0.110 |
Why?
|
| Statistics as Topic | 2 | 2013 | 117 | 0.110 |
Why?
|
| Time Factors | 3 | 2023 | 1742 | 0.110 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 1067 | 0.110 |
Why?
|
| Cannabidiol | 1 | 2012 | 5 | 0.110 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2013 | 215 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2013 | 131 | 0.110 |
Why?
|
| Educational Status | 2 | 2019 | 313 | 0.100 |
Why?
|
| Linear Models | 1 | 2012 | 275 | 0.100 |
Why?
|
| Memory, Short-Term | 2 | 2013 | 49 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2013 | 362 | 0.100 |
Why?
|
| Personality Inventory | 2 | 2016 | 75 | 0.100 |
Why?
|
| Unsafe Sex | 2 | 2010 | 161 | 0.090 |
Why?
|
| Predictive Value of Tests | 5 | 2012 | 400 | 0.090 |
Why?
|
| Suicide, Attempted | 1 | 2012 | 91 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 17 | 0.090 |
Why?
|
| Motor Skills | 1 | 2010 | 33 | 0.090 |
Why?
|
| Games, Experimental | 1 | 2009 | 3 | 0.090 |
Why?
|
| Hippocampus | 3 | 2021 | 561 | 0.090 |
Why?
|
| Affective Symptoms | 1 | 2010 | 57 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 259 | 0.090 |
Why?
|
| Severity of Illness Index | 5 | 2016 | 610 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2012 | 2026 | 0.080 |
Why?
|
| Age Factors | 3 | 2006 | 1033 | 0.080 |
Why?
|
| Smoking | 1 | 2015 | 940 | 0.080 |
Why?
|
| Stroop Test | 2 | 2021 | 2 | 0.080 |
Why?
|
| Homosexuality, Male | 1 | 2013 | 458 | 0.070 |
Why?
|
| Animals | 3 | 2023 | 15081 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 53 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2007 | 149 | 0.070 |
Why?
|
| Reference Standards | 1 | 2006 | 52 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2007 | 253 | 0.070 |
Why?
|
| Temperament | 1 | 2005 | 31 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2005 | 107 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 562 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 131 | 0.060 |
Why?
|
| Verbal Behavior | 1 | 2004 | 13 | 0.060 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 174 | 0.060 |
Why?
|
| Language | 1 | 2005 | 157 | 0.060 |
Why?
|
| Aspartic Acid | 1 | 2003 | 47 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 357 | 0.060 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2015 | 25 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2003 | 24 | 0.050 |
Why?
|
| Psychopathology | 1 | 2021 | 15 | 0.050 |
Why?
|
| Personality Disorders | 1 | 2021 | 10 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 46 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2021 | 10 | 0.050 |
Why?
|
| Rural Population | 1 | 2023 | 294 | 0.050 |
Why?
|
| Task Performance and Analysis | 1 | 2021 | 37 | 0.050 |
Why?
|
| Awareness | 1 | 2021 | 65 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2021 | 117 | 0.050 |
Why?
|
| Florida | 1 | 2021 | 410 | 0.040 |
Why?
|
| Prevalence | 2 | 2019 | 1455 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 356 | 0.040 |
Why?
|
| Aged | 2 | 2012 | 6741 | 0.040 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2018 | 3 | 0.040 |
Why?
|
| Habits | 1 | 2018 | 7 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 61 | 0.040 |
Why?
|
| South America | 1 | 2018 | 15 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2018 | 23 | 0.040 |
Why?
|
| North America | 1 | 2018 | 67 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 75 | 0.040 |
Why?
|
| Europe | 1 | 2018 | 101 | 0.040 |
Why?
|
| Australia | 1 | 2018 | 76 | 0.040 |
Why?
|
| Compulsive Behavior | 1 | 2018 | 30 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 242 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 197 | 0.040 |
Why?
|
| Personality Tests | 1 | 2016 | 7 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2021 | 1418 | 0.040 |
Why?
|
| Culture | 1 | 2018 | 173 | 0.040 |
Why?
|
| Legislation, Drug | 1 | 2016 | 5 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 448 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 108 | 0.030 |
Why?
|
| ROC Curve | 2 | 2004 | 138 | 0.030 |
Why?
|
| Wechsler Scales | 1 | 2013 | 6 | 0.030 |
Why?
|
| Reading | 1 | 2013 | 13 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 89 | 0.030 |
Why?
|
| Chicago | 1 | 2013 | 30 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2012 | 15 | 0.030 |
Why?
|
| Hypertension | 1 | 2019 | 796 | 0.030 |
Why?
|
| Association Learning | 1 | 2012 | 30 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2013 | 157 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2013 | 212 | 0.030 |
Why?
|
| Algorithms | 1 | 2013 | 465 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 62 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 98 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 111 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2007 | 53 | 0.020 |
Why?
|
| HIV Seronegativity | 1 | 2007 | 39 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 225 | 0.020 |
Why?
|
| Putamen | 1 | 2006 | 15 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 218 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 9 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2004 | 88 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 290 | 0.010 |
Why?
|
| Semantics | 1 | 2004 | 28 | 0.010 |
Why?
|
| Creatine | 1 | 2003 | 8 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 2003 | 11 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 601 | 0.010 |
Why?
|
| Inositol | 1 | 2003 | 21 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2003 | 48 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2003 | 289 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 204 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 859 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 418 | 0.010 |
Why?
|
| Aging | 1 | 2005 | 664 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 484 | 0.010 |
Why?
|